SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-19-012565
Filing Date
2019-05-07
Accepted
2019-05-07 19:01:54
Documents
2
Period of Report
2019-05-07

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 6045
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 4588
  Complete submission text file 0000899243-19-012565.txt   12036
Mailing Address C/O BARRIER THERAPEUTICS, INC. 600 COLLEGE ROAD EAST, SUITE 3200 PRINCETON NJ 08540
Business Address
VANLENT ANNE (Reporting) CIK: 0001229243 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38886 | Film No.: 19804683

Mailing Address 195 CHURCH STREET 14TH FLOOR NEW HAVEN CT 06510
Business Address 195 CHURCH STREET 14TH FLOOR NEW HAVEN CT 06510 203-304-2499
Trevi Therapeutics, Inc. (Issuer) CIK: 0001563880 (see all company filings)

IRS No.: 450834299 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations